-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Omega Healthcare Invts, Raises Price Target to $56

Benzinga·11/11/2026 21:18:12
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $56.